← Back to Search

Strength vs Power Training for Patellofemoral Pain (STRIPE Trial)

N/A
Recruiting
Led By Neal Glaviano, PhD
Research Sponsored by University of Connecticut
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants to be between the ages of 18-40 years old.
Insidious onset of symptoms greater than 3 months.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention and then 6, 12, 18, and 24 months post-intervention.
Awards & highlights

STRIPE Trial Summary

This trial compares STRIPE, a novel 6-week strength training program, to a standard of care program to see if it reduces patellofemoral pain, improves function, and reduces recurrence.

Who is the study for?
This trial is for people aged 18-40 with patellofemoral pain that started on its own over 3 months ago and hurts at least a bit during activities like sitting long, jumping, or climbing stairs. It's not for those with other knee issues, history of knee cap dislocation, meniscus or ligament injuries, leg surgery, or pain from the lower back.Check my eligibility
What is being tested?
The study compares two 6-week rehab programs for knee pain: Standard of Care (SOC) vs. Strength Training with Power Exercises (STRIPE). It will check which program better reduces pain and prevents it from coming back while improving leg strength and squatting form.See study design
What are the potential side effects?
While specific side effects aren't listed here, exercise-based rehab can sometimes lead to muscle soreness, joint discomfort or exacerbation of existing symptoms if not done correctly.

STRIPE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 40 years old.
Select...
My symptoms started slowly over more than 3 months ago.

STRIPE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention and then 6, 12, 18, and 24 months post-intervention.
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention and then 6, 12, 18, and 24 months post-intervention. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in hip adduction during a single leg squat
Change in hip rate of torque development
Change in knee pain.
+3 more
Secondary outcome measures
Change in cognitive factors
Change in coping strategy
Change in physical activity
+2 more

STRIPE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Strength Training Rehabilitation Incorporating Power Exercises (STRIPE)Experimental Treatment1 Intervention
Those in the STRIPE group will complete two power and one strength training sessions a week. All participants will be provided an educational pamphlet and exercises will be divided into four components - hip abductors, hip extensors, core, and quadriceps muscles. The load magnitude will be greater than 60% of the 1RM, with the goal of continually loading against heavy resistance. Participants will complete 4 sets of 6 repetitions, with 3-5 minutes of rest between sets. Time under tension will be prescribed as <1 second for the concentric phase and 1 second for the eccentric phase of the exercise. The strength training sessions will adhere to same parameters as the SOC. Hip abductor, hip extensor, and core exercises will be initiated during week 1 and continued for the 6-week intervention, while quadriceps focused exercises will be introduced in weeks 3-6.
Group II: Standard of Care (SOC)Active Control1 Intervention
The SOC rehabilitation group will complete three strength sessions a week. All participants will be provided an educational pamphlet and exercises will be divided into four components - hip abductors, hip extensors, core, and quadriceps muscles. The load magnitude for exercises will be between 60-70% of their 1 repetition max (1RM), with 3 sets of 12 repetitions and a 2-3-minute rest between sets. Time under tension will be prescribed as slow to moderate, with a 2-second concentric phase and 2-second eccentric phase for each exercise. Hip abductor, hip extensor, and core exercises will be initiated during week 1 and continued for the 6-week intervention, while quadriceps focused exercises will be introduced in weeks 3-6.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Patellofemoral Pain Syndrome (PFPS) include strength training and power exercises. Strength training focuses on enhancing the strength of the quadriceps and hip muscles, which helps stabilize the patella and alleviate pain. Power exercises involve rapid, forceful movements that improve muscle power and neuromuscular control, further aiding in patellar stability. These treatments are essential for PFPS patients as they correct muscle imbalances and biomechanical issues, leading to reduced pain and improved functional outcomes.

Find a Location

Who is running the clinical trial?

University of ConnecticutLead Sponsor
186 Previous Clinical Trials
160,173 Total Patients Enrolled
University of Central FloridaOTHER
80 Previous Clinical Trials
1,098,166 Total Patients Enrolled
University of ToledoOTHER
7 Previous Clinical Trials
654 Total Patients Enrolled

Media Library

Standard of Care Rehabilitation (SOC) Clinical Trial Eligibility Overview. Trial Name: NCT05403944 — N/A
Patellofemoral Pain Syndrome Research Study Groups: Strength Training Rehabilitation Incorporating Power Exercises (STRIPE), Standard of Care (SOC)
Patellofemoral Pain Syndrome Clinical Trial 2023: Standard of Care Rehabilitation (SOC) Highlights & Side Effects. Trial Name: NCT05403944 — N/A
Standard of Care Rehabilitation (SOC) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05403944 — N/A
~12 spots leftby Sep 2024